Skip to main content

Advertisement

Table 2 Summary of efficacy endpoints in current study

From: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases

N No-Tx Ctrl Pre-Tx Ctrl Tx P value
20 117 117
Mean duration of outbreaks (days) 6.70 8.77 2.87 P < 0.001 (No-Tx Ctrl)
P < 0.0001 (Pre-Tx Ctrl)
Median duration of outbreaks (days) 5.00 7.00 2.00
On a scale of 1–7a 3.95 3.35 5.82 P < 0.0001 (both controls)
  1. Tx treatment
  2. aWhere 1 is “very long time” and 7 is “didn’t have symptoms”